Jianfeng Group Lin2015 -001 (Announcement of Jianfeng Group on Progress of Naisikang)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 Number: Pro 2015-001
Bond Abbreviations: 13 Spike 01 Bond Code: 122227
Bond Abbreviations: 13 Spike 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Progress Announcement on Jianfeng Pharmaceutical's Acquisition of Naisikang's Equity
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
2014 7 29 , the company once announced that Zhejiang Jianfeng pharmaceutical co., ltd., the controlling subsidiary of the company, signed the "framework agreement on equity transfer of Zhejiang nesikang pharmaceutical co., ltd." (hereinafter referred to as the "framework agreement") with Creative Medicine and Xi' an zizhitong investment co., ltd, it is proposed to transfer its 70% and 25% stake in Zhejiang Niskang Pharmaceutical Co., Ltd. For the above matters, please refer to the "Prompt Announcement of Zhejiang Jianfeng Group Co., Ltd. on Signing of Equity Transfer Framework Agreement by Subsidiaries" issued by the Company on , , , , , , , ,
.After the framework agreement was signed, according to the agreement, we hired audit, evaluation and other intermediary agencies with securities qualification to conduct a comprehensive audit, evaluation and due diligence on Zhejiang Nestkang Pharmaceutical Co., Ltd. , and conducted many consultations and negotiations with the equity transferor, however, due to the failure to solve the environmental protection problems of
Zhejiang Naisikang Pharmaceutical Co., Ltd., a consensus could not be reached.In view of the fact that the exclusive period stipulated in the Framework Agreement has expired, after friendly negotiation, all parties jointly decided to terminate the equity transfer of Nessikang Company. On April 13, 2015, parties
signed the Memorandum on Termination of the Framework Agreement on Equity Transfer of Zhejiang Nessikang Pharmaceutical Co., Ltd. The main contents of the memorandum are as follows:1. The parties agree to terminate the Framework Agreement on Equity Transfer of Zhejiang Nestkang Pharmaceutical Co., Ltd. signed on July 28, 2014.
2. Each party shall bear the expenses (audit and evaluation expenses) paid for the above-mentioned equity transfer, and shall not claim compensation or compensation from the other party.
3. Creative Medicine and Xi 'an Zizhitong Investment Co., Ltd. may seek a third party to contact, negotiate and negotiate the above-mentioned equity transfer of Zhejiang Naisikang Pharmaceutical Co., Ltd.
The termination of the equity transfer of Zhejiang Naisikang Pharmaceutical Co., Ltd.
will not have a material adverse impact on the production and operation of the Company.is hereby announced
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
More information
The company organized "charity one day donation"
On the morning of October 22, in the lobby on the first floor of Jianfeng Building, all cadres and employees of the group headquarters and subordinate enterprises working in Jianfeng Building participated in the 2021 "Charity Day Donation" activity to offer their love to Jinhua charity. In the next few days, the company's subordinate enterprises also organized "charity one-day donation" activities one after another.
2021
11-01
The company organizes new employee induction training
"Growth is more important than success. I hope everyone can become the backbone and pillars of the peak as soon as possible." On September 2, Yu Jianhong, general manager of the group company, put forward ardent hopes in the face of new employees. On the 2nd and 3rd, the group company organized induction training for new employees recruited in the past year. The group company chairman Jiang Xiaomeng, general manager Yu Jianhong and other leaders and relevant department heads gave lectures to them.
2021
09-13
Daye Peak: Typical Regional Industrial Green Development
On August 23, Huangshi Radio and Television Station broadcast the special program of "Strengthening Overall Planning and Promoting Energy Saving and Emission Reduction in Industrial Field". Daye Jianfeng Cement Company, as a typical enterprise with outstanding achievements in establishing green factories and energy saving and emission reduction in Huangshi area, appeared in the program.
2021
09-01
Yunnan Peak Helps Border Epidemic Prevention and Control
On August 22, Yunnan Peak Cement Company, through the Red Cross Society of Pu'er City and the Epidemic Prevention Headquarters of Pu'er City, donated vacuum insulation pots with a total value of 800000 yuan to the four border counties for the prevention and control of the new coronary pneumonia epidemic in the border area, and supported the prevention and control of the epidemic at the border with practical actions.
2021
09-01
Group Party Committee to Learn "July 1" Important Speech
On August 13, the party committee of the group company held a special meeting to collectively study General Secretary Xi Jinping's important speech at the celebration meeting of the 100 anniversary of the founding of the Communist Party of China, convey the requirements of the party committee at a higher level, and make arrangements for organizing party members of the company to study the "July 1" speech.
2021
08-23
Spike Ranked 2020 China's Top 100 Cement Clinker Production Capacity
Recently, the company received the "2020 China Cement Clinker Production Capacity Top 100" plaque issued by China Cement Network. The ranking of China's top 100 cement clinker production capacity is organized and evaluated by China Cement Network, an authoritative information platform for the domestic cement industry. It is released according to the actual clinker production capacity of each cement enterprise at the end of last year. The company has been ranked in the top 100 list for many consecutive years.
2021
08-23